Concept Submission Process
Summary of Investigator Initiated Research (IIR) Process
  • 1. Submission expand_more
    • Brief Concept expand_more
      • Investigator Actions
        • Submit a Concept
      • Estimated Timeline
        • Confirmation of concept under review within 10 business days
        • Communication of decision regarding interest within 30 days
    • IIR Application Packet expand_more
      • Investigator Actions
        • Executed Letter of Confidentiality
        • Application
        • Proposal/Protocol
        • Curriculum Vitae
        • Draft Budget (if applicable)
      • Estimated Timeline
        • Confirmation of Application Packet under review within 10 business days
        • Inform applicant of decision within 90 days of receipt of completed application packet
    • Protocol expand_more
      • Investigator Actions
        • If not submitted with application packet, then full protocol must be submitted
        • Final budget (if applicable)
      • Estimated Timeline
        • Full protocol to be provided by investigator within 60 days
  • 2. Execution expand_more
    • Executed Clinical Trial Agreement expand_more
      • Investigator Action
        • Execution of final Clinical Trial Agreement
    • Initial Drug Shipment expand_more
      • Investigator Actions
        • Regulatory Authority Approval (if applicable)
        • Institutional Review Board/Ethical Review Board/Ethics Committee Approval
        • Investigational Device Exemption Approval (if applicable)
        • Executed Clinical Trial Agreement
        • Institutional Review Board/Ethical Review Board/Ethics Committee Approved Protocol
      • Estimated Timeline
        • Drug will be shipped approximately 4-9 months post Regulatory Authority Approval and fully executed Clinical Trial Agreement
  • 3. Research expand_more
    • Study Status expand_more
      • Investigator Action
        • Quarterly Enrollment
        • Serious Adverse Events
        • Protocol Amendment
        • Institutional Review Board/Ethical Review Board/Ethics Committee Renewals
    • Publication expand_more
      • Investigator Actions
        • Interim presentation and/or publication
    • Final Reconcilliation expand_more
      • Investigator Actions
        • Final study report
        • Confirmation of Study Drug Destruction
        • Institutional Review Board/Ethical Review Board/Ethics Committee Letter of Study Closure
Submit a Concept
If you do not see your country listed, please visit the FAQ page
Choose Request type

If you do not see your compound listed, please visit the FAQ page

By completing this form and clicking submit, you agree to the Privacy Statement linked to this site and are consenting to have your e-mail address and personal information you have provided to be collected and used by Eli Lilly and Company and its affiliates and representatives for processing your request for Investigator Initiated Research. Your information will be retained within a secure environment at Lilly.